180 related articles for article (PubMed ID: 20197265)
1. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial.
Dunlay SM; Gheorghiade M; Reid KJ; Allen LA; Chan PS; Hauptman PJ; Zannad F; Maggioni AP; Swedberg K; Konstam MA; Spertus JA
Eur J Heart Fail; 2010 Apr; 12(4):367-74. PubMed ID: 20197265
[TBL] [Abstract][Full Text] [Related]
2. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.
Ambrosy AP; Khan H; Udelson JE; Mentz RJ; Chioncel O; Greene SJ; Vaduganathan M; Subacuis HP; Konstam MA; Swedberg K; Zannad F; Maggioni AP; Gheorghiade M; Butler J
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27140204
[TBL] [Abstract][Full Text] [Related]
3. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
Konstam MA; Gheorghiade M; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
JAMA; 2007 Mar; 297(12):1319-31. PubMed ID: 17384437
[TBL] [Abstract][Full Text] [Related]
5. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Greene SJ; Gheorghiade M; Vaduganathan M; Ambrosy AP; Mentz RJ; Subacius H; Maggioni AP; Nodari S; Konstam MA; Butler J; Filippatos G;
Eur J Heart Fail; 2013 Dec; 15(12):1401-11. PubMed ID: 23845795
[TBL] [Abstract][Full Text] [Related]
6. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
Sarma S; Mentz RJ; Kwasny MJ; Fought AJ; Huffman M; Subacius H; Nodari S; Konstam M; Swedberg K; Maggioni AP; Zannad F; Bonow RO; Gheorghiade M;
Eur J Heart Fail; 2013 Feb; 15(2):194-202. PubMed ID: 23059198
[TBL] [Abstract][Full Text] [Related]
7. Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Lanfear DE; Sabbah HN; Goldsmith SR; Greene SJ; Ambrosy AP; Fought AJ; Kwasny MJ; Swedberg K; Yancy CW; Konstam MA; Maggioni AP; Zannad F; Gheorghiade M;
Circ Heart Fail; 2013 Jan; 6(1):47-52. PubMed ID: 23239836
[TBL] [Abstract][Full Text] [Related]
8. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.
Greene SJ; Vaduganathan M; Wilcox JE; Harinstein ME; Maggioni AP; Subacius H; Zannad F; Konstam MA; Chioncel O; Yancy CW; Swedberg K; Butler J; Bonow RO; Gheorghiade M;
JACC Heart Fail; 2013 Dec; 1(6):488-96. PubMed ID: 24622000
[TBL] [Abstract][Full Text] [Related]
10. Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).
Shah AN; Mentz RJ; Gheorghiade M; Kwasny MJ; Fought AJ; Zannad F; Swedberg K; Maggioni AP; Konstam MA
Am J Cardiol; 2012 Dec; 110(12):1803-8. PubMed ID: 22999071
[TBL] [Abstract][Full Text] [Related]
11. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
O'Connor CM; Miller AB; Blair JE; Konstam MA; Wedge P; Bahit MC; Carson P; Haass M; Hauptman PJ; Metra M; Oren RM; Patten R; Piña I; Roth S; Sackner-Bernstein JD; Traver B; Cook T; Gheorghiade M;
Am Heart J; 2010 May; 159(5):841-849.e1. PubMed ID: 20435194
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
Gheorghiade M; Pang PS; Ambrosy AP; Lan G; Schmidt P; Filippatos G; Konstam M; Swedberg K; Cook T; Traver B; Maggioni A; Burnett J; Grinfeld L; Udelson J; Zannad F
Heart Fail Rev; 2012 May; 17(3):485-509. PubMed ID: 21932146
[TBL] [Abstract][Full Text] [Related]
13. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M;
Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life.
Allen LA; Gheorghiade M; Reid KJ; Dunlay SM; Chan PS; Hauptman PJ; Zannad F; Konstam MA; Spertus JA
Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):389-98. PubMed ID: 21693723
[TBL] [Abstract][Full Text] [Related]
15. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Gheorghiade M; Konstam MA; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
JAMA; 2007 Mar; 297(12):1332-43. PubMed ID: 17384438
[TBL] [Abstract][Full Text] [Related]
16. Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial).
Vaduganathan M; Patel RB; Mentz RJ; Subacius H; Chatterjee NA; Greene SJ; Ambrosy AP; Maggioni AP; Udelson JE; Swedberg K; Konstam MA; O'Connor CM; Butler J; Gheorghiade M; Zannad F
Am J Cardiol; 2018 Jul; 122(2):255-260. PubMed ID: 29731121
[TBL] [Abstract][Full Text] [Related]
17. Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).
Cook TD; Greene SJ; Kalogeropoulos AP; Fonarow GC; Zea R; Swedberg K; Zannad F; Maggioni AP; Konstam MA; Gheorghiade M; Butler J
Am J Cardiol; 2016 Feb; 117(4):611-616. PubMed ID: 26742474
[TBL] [Abstract][Full Text] [Related]
18. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
Blair JE; Khan S; Konstam MA; Swedberg K; Zannad F; Burnett JC; Grinfeld L; Maggioni AP; Udelson JE; Zimmer CA; Ouyang J; Chen CF; Gheorghiade M;
Eur Heart J; 2009 Jul; 30(13):1666-73. PubMed ID: 19411662
[TBL] [Abstract][Full Text] [Related]
19. Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
Lim NK; Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Oh BH; Park HY
J Cardiol; 2019 Feb; 73(2):108-113. PubMed ID: 30360893
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.
Yee D; Novak E; Platts A; Nassif ME; LaRue SJ; Vader JM
Am J Cardiol; 2019 Mar; 123(5):807-812. PubMed ID: 30587373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
